Skip to content

Clarus Funds

Clarus Funds, now operating as Blackstone Life Sciences, focuses on late-stage life sciences investments, particularly in biopharmaceuticals and medical technologies. The organization collaborates with major pharmaceutical companies to fund and develop innovative therapies.

Founded
2005
Recorded stages
Series C, Series D, Growth Equity
Focus sectors
Biotech, Healthcare
Recorded regions
North America, Global

Online destinations

Find Clarus Funds online

Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.

Official links

Pages the organization runs itself.

Overview

Clarus Funds, part of Blackstone Life Sciences, specializes in late-stage investments in the life sciences sector, particularly in the development of medicines and technologies. Founded in 2005, the organization collaborates with pharmaceutical, biotech, and medical technology companies to address unmet medical needs. Their investment strategy emphasizes funding innovative core products from credible counterparties, aiming for market-unrelated returns at lower risk. Notable collaborations include significant partnerships with Moderna and Alnylam Pharmaceuticals, reflecting their commitment to advancing healthcare solutions.

Focus

Clarus Funds primarily invests in late-stage life science products and companies, focusing on funding the development of innovative core products from credible counterparties. Their strategy aims to generate market-unrelated returns at lower risk, with a strong emphasis on collaboration across various therapeutic areas within the life sciences sector.

Support

Clarus Funds adds value to its portfolio companies through strategic collaborations, funding for R&D, and leveraging its extensive network within the pharmaceutical and biotech industries to facilitate the development and commercialization of innovative therapies.

Questions

What are Clarus Funds' investment criteria?

Clarus Funds primarily invests in late-stage life science products and companies, focusing on Series C and Series D funding rounds. They seek innovative core products from credible counterparties that address significant medical needs.

How can I pitch to Clarus Funds?

Founders can submit their pitches through the Clarus Funds website at clarusfunds.com. It is recommended to include detailed information about the product, market potential, and the team.

What makes Clarus Funds different from other investors?

Clarus Funds specializes in the life sciences sector and has a strong focus on late-stage investments. Their affiliation with Blackstone Life Sciences provides them with extensive resources and expertise in funding and executing clinical trials.

What is the geographic scope of Clarus Funds' investments?

Clarus Funds primarily operates in the United States but is open to opportunities in other regions, particularly where innovative life sciences products are being developed.

What kind of post-investment support does Clarus Funds provide?

Clarus Funds actively engages with portfolio companies, offering operational support and strategic guidance to help them navigate the complexities of bringing their products to market.

What is the typical check size for investments?

Clarus Funds typically invests significant amounts in late-stage rounds, with check sizes varying based on the specific needs of the portfolio company and the stage of development.

Check your startup’s fit

Check your startup’s fit with Clarus Funds

Similar investors

Organizations that do similar work to Clarus Funds.

All investors
Bain Capital logoInvestor

Global private investment firm with diverse strategies.

Hamilton Lane logoInvestor

Investing in private markets for over 30 years.

Magnetar logoInvestor

Innovative investment solutions across diverse asset classes.

AEA Investors logoInvestor

Transforming businesses for long-term success.

Superscout Pro

Find faster. Show up verified. Keep your deals private.

$99a year, or $12 a month
Get Pro

Is this page right?Reviewed · How the research works

Something's off